J, S., R, S., P, K., & OA, C. (2026). How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis?-clinical considerations in haematology. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 32(6), 936. https://doi.org/10.1016/j.cmi.2026.03.001
Chicago Style (17th ed.) CitationJ, Stemler, Sprute R, Koehler P, and Cornely OA. "How to Safely Discontinue Antifungal Treatment in Invasive Pulmonary Aspergillosis?-clinical Considerations in Haematology." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 32, no. 6 (2026): 936. https://doi.org/10.1016/j.cmi.2026.03.001.
MLA (9th ed.) CitationJ, Stemler, et al. "How to Safely Discontinue Antifungal Treatment in Invasive Pulmonary Aspergillosis?-clinical Considerations in Haematology." Clinical Microbiology and Infection : The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, vol. 32, no. 6, 2026, p. 936, https://doi.org/10.1016/j.cmi.2026.03.001.
